Bio/Pharma News

GSK’s Malaria Vaccine Gets Positive Opinion from EMA

July 24, 2015

EMA gives GSK’s malaria candidate vaccine a positive opinion for the prevention of malaria in young children in sub-Saharan Africa.

MedImmune Forms Cell Engineering Pact with University of Sheffield

July 22, 2015

MedImmune will provide funding and in-kind contributions to support University of Sheffield research projects to address key challenges in cell engineering.

Eisai Transfers North Carolina Facility to Biogen

July 21, 2015

Biogen will take ownership of Eisai's Research Triangle Park manufacturing campus and will manufacture both oral solid-dose and parenteral drugs for Eisai.

Insect in IV Solution Prompts Baxter Recall

July 20, 2015

Baxter has initiated a voluntary recall of two lots of IV solutions due to the potential presence of particulate matter.

Sanofi Announces New, Global Business Unit Structure

July 16, 2015

Sanofi's new business-unit structure focuses on growth drivers.

GSK Ships Flu Vaccine

July 16, 2015

GSK accelerates delivery timeline for US quadrivalent flu vaccine.

Mylan’s Withdrawn Difficult-to-Administer Prefilled Syringe Still on Market, Sparks FDA Concern

July 15, 2015

Mylan issued a voluntary withdrawal of calcium chloride intravenous infusion 10% w/v 10mL prefilled syringe due to difficulties in administration.

GSK and Francis Crick Institute Partner on New Scientific Discoveries

July 14, 2015

This collaboration is said to be the first established between the Crick and a pharmaceutical company.

Teva Launches First Generic Axert Tablets in the US

July 09, 2015

Teva has launched the generic version of almotriptan malate (Axert), 6.25 mg and 12.5 mg, in the United States.

Officials Propose Corporate Tax Holiday

July 09, 2015

Senators encourage the repatriation of offshore funds in a new report targeting the pharmaceutical industry.